| UniProt ID | SPEE_HUMAN | |
|---|---|---|
| UniProt AC | P19623 | |
| Protein Name | Spermidine synthase | |
| Gene Name | SRM | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 302 | |
| Subcellular Localization | ||
| Protein Description | Catalyzes the production of spermidine from putrescine and decarboxylated S-adenosylmethionine (dcSAM). Has a strong preference for putrescine as substrate, and has very low activity towards 1,3-diaminopropane. Has extremely low activity towards spermidine.. | |
| Protein Sequence | MEPGPDGPAASGPAAIREGWFRETCSLWPGQALSLQVEQLLHHRRSRYQDILVFRSKTYGNVLVLDGVIQCTERDEFSYQEMIANLPLCSHPNPRKVLIIGGGDGGVLREVVKHPSVESVVQCEIDEDVIQVSKKFLPGMAIGYSSSKLTLHVGDGFEFMKQNQDAFDVIITDSSDPMGPAESLFKESYYQLMKTALKEDGVLCCQGECQWLHLDLIKEMRQFCQSLFPVVAYAYCTIPTYPSGQIGFMLCSKNPSTNFQEPVQPLTQQQVAQMQLKYYNSDVHRAAFVLPEFARKALNDVS | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 1 | Acetylation | -------MEPGPDGP -------CCCCCCCC | 14.66 | 22223895 | |
| 11 | Phosphorylation | GPDGPAASGPAAIRE CCCCCCCCCCCHHCC | 47.63 | 24850871 | |
| 17 | Dimethylation | ASGPAAIREGWFRET CCCCCHHCCCCEECC | 31.48 | - | |
| 17 | Methylation | ASGPAAIREGWFRET CCCCCHHCCCCEECC | 31.48 | 115384391 | |
| 22 | Dimethylation | AIREGWFRETCSLWP HHCCCCEECCCCCCC | 31.63 | - | |
| 22 | Methylation | AIREGWFRETCSLWP HHCCCCEECCCCCCC | 31.63 | 115390147 | |
| 46 | Phosphorylation | QLLHHRRSRYQDILV HHHHHCHHHCCCEEE | 34.98 | 28152594 | |
| 48 | Phosphorylation | LHHRRSRYQDILVFR HHHCHHHCCCEEEEE | 16.28 | 28152594 | |
| 56 | Phosphorylation | QDILVFRSKTYGNVL CCEEEEECCCCCCEE | 20.20 | 24719451 | |
| 57 | Ubiquitination | DILVFRSKTYGNVLV CEEEEECCCCCCEEE | 41.32 | 21890473 | |
| 72 | Phosphorylation | LDGVIQCTERDEFSY ECCEEEECCCCCCCH | 20.06 | 24719451 | |
| 96 | Malonylation | CSHPNPRKVLIIGGG CCCCCCCEEEEECCC | 42.52 | 26320211 | |
| 96 | Ubiquitination | CSHPNPRKVLIIGGG CCCCCCCEEEEECCC | 42.52 | 23000965 | |
| 113 | Ubiquitination | GVLREVVKHPSVESV HHHHHHHCCCCCCCE | 55.78 | 21963094 | |
| 116 | Phosphorylation | REVVKHPSVESVVQC HHHHCCCCCCCEEEC | 37.93 | - | |
| 123 | Glutathionylation | SVESVVQCEIDEDVI CCCCEEECCCCHHHH | 3.15 | 22555962 | |
| 134 | Ubiquitination | EDVIQVSKKFLPGMA HHHHHHCHHHCCCCE | 49.00 | 23000965 | |
| 134 | Acetylation | EDVIQVSKKFLPGMA HHHHHHCHHHCCCCE | 49.00 | 25953088 | |
| 135 | Acetylation | DVIQVSKKFLPGMAI HHHHHCHHHCCCCEE | 44.63 | 25953088 | |
| 135 | Ubiquitination | DVIQVSKKFLPGMAI HHHHHCHHHCCCCEE | 44.63 | 23000965 | |
| 144 | Phosphorylation | LPGMAIGYSSSKLTL CCCCEEEECCCEEEE | 10.16 | 21406692 | |
| 145 | Phosphorylation | PGMAIGYSSSKLTLH CCCEEEECCCEEEEE | 23.95 | 25159151 | |
| 146 | Phosphorylation | GMAIGYSSSKLTLHV CCEEEECCCEEEEEE | 24.02 | 25159151 | |
| 147 | Phosphorylation | MAIGYSSSKLTLHVG CEEEECCCEEEEEEC | 26.24 | 25159151 | |
| 178 | Sulfoxidation | ITDSSDPMGPAESLF EECCCCCCCCHHHHH | 13.91 | 30846556 | |
| 183 | Phosphorylation | DPMGPAESLFKESYY CCCCCHHHHHHHHHH | 41.01 | 24719451 | |
| 193 | Sulfoxidation | KESYYQLMKTALKED HHHHHHHHHHHHHHC | 1.82 | 30846556 | |
| 194 | Ubiquitination | ESYYQLMKTALKEDG HHHHHHHHHHHHHCC | 38.96 | 21906983 | |
| 198 | Acetylation | QLMKTALKEDGVLCC HHHHHHHHHCCEEEE | 51.82 | 26051181 | |
| 198 | Ubiquitination | QLMKTALKEDGVLCC HHHHHHHHHCCEEEE | 51.82 | 21963094 | |
| 253 | Sumoylation | IGFMLCSKNPSTNFQ EEEEEEECCCCCCCC | 72.40 | - | |
| 253 | Ubiquitination | IGFMLCSKNPSTNFQ EEEEEEECCCCCCCC | 72.40 | - | |
| 274 | Sulfoxidation | TQQQVAQMQLKYYNS CHHHHHHHHHHHCCC | 3.48 | 30846556 | |
| 277 | Sumoylation | QVAQMQLKYYNSDVH HHHHHHHHHCCCHHH | 28.88 | - | |
| 277 | Ubiquitination | QVAQMQLKYYNSDVH HHHHHHHHHCCCHHH | 28.88 | 21963094 | |
| 277 | Acetylation | QVAQMQLKYYNSDVH HHHHHHHHHCCCHHH | 28.88 | 26051181 | |
| 278 | Phosphorylation | VAQMQLKYYNSDVHR HHHHHHHHCCCHHHH | 19.24 | 28152594 | |
| 279 | Phosphorylation | AQMQLKYYNSDVHRA HHHHHHHCCCHHHHH | 13.45 | 28152594 | |
| 296 | Sumoylation | VLPEFARKALNDVS- HCHHHHHHHHHCCC- | 54.52 | - | |
| 296 | Ubiquitination | VLPEFARKALNDVS- HCHHHHHHHHHCCC- | 54.52 | 29967540 | |
| 296 | Sumoylation | VLPEFARKALNDVS- HCHHHHHHHHHCCC- | 54.52 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of SPEE_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SPEE_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SPEE_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| CRK_HUMAN | CRK | physical | 26344197 | |
| HXK2_HUMAN | HK2 | physical | 26344197 | |
| TIPRL_HUMAN | TIPRL | physical | 26344197 | |
| EFHC1_HUMAN | EFHC1 | physical | 27173435 |
| Kegg Disease | |
|---|---|
| There are no disease associations of PTM sites. | |
| OMIM Disease | |
| There are no disease associations of PTM sites. | |
| Kegg Drug | |
| There are no disease associations of PTM sites. | |
| DrugBank | |
| DB00118 | S-Adenosylmethionine |
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY. | |